Today: 29 April 2026

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Edinburgh Hogmanay power cuts: Grassmarket pubs warn blackouts could hit New Year rush

Edinburgh Hogmanay power cuts: Grassmarket pubs warn blackouts could hit New Year rush

Repeated power outages hit Edinburgh’s Grassmarket on Dec. 30 and 31, disrupting festive trade as venues prepared for Hogmanay, operators said. SP Energy Networks blamed an intermittent fault and said extra staff were on standby. Businesses reported lost bookings and wasted stock, with some venues losing entire peak services. Operators urged the council and network to publish plans for upgrades and contingency measures.
1 January 2026
·
Visa stock today: $500 million escrow move reshapes share conversion math as markets shut

Visa stock today: $500 million escrow move reshapes share conversion math as markets shut

Visa lowered conversion rates for its class B-1 and B-2 shares after a $500 million litigation escrow deposit, according to a regulatory filing. The changes, effective Dec. 23, reduce the number of class A shares issued if conversion occurs. Visa shares closed down 0.8% at $350.71 ahead of the New Year holiday. The company has not set a date for its next earnings report.
1 January 2026
·
Corcept Therapeutics stock tanks 50% after FDA relacorilant setback — what’s next for CORT

Corcept Therapeutics stock tanks 50% after FDA relacorilant setback — what’s next for CORT

Corcept Therapeutics shares fell 50.4% to $34.80 after the FDA declined to approve relacorilant for Cushing’s-related hypertension, citing a need for more evidence of effectiveness. The company plans to meet with the agency to discuss next steps. Wolfe Research downgraded the stock and removed projected sales for the indication. Trading volume reached about 20.16 million shares.
1 January 2026
··
Axsome stock jumps 23% after FDA sets April 30 deadline for Alzheimer’s agitation review

Axsome stock jumps 23% after FDA sets April 30 deadline for Alzheimer’s agitation review

Axsome Therapeutics shares surged 22.9% to $182.64 after the FDA granted priority review to its application for AXS-05 in treating agitation in Alzheimer’s disease, setting an April 30 decision date. The company also plans to file for approval of AXS-12 for cataplexy in narcolepsy this month, following supportive FDA meeting minutes. Trading volume reached 3.1 million shares.
1 January 2026
··
INBS stock whipsaws after Intelligent Bio Solutions lines up $10 million funding

INBS stock whipsaws after Intelligent Bio Solutions lines up $10 million funding

Intelligent Bio Solutions shares jumped 132% to $9.53 before dropping 14% after-hours as the company announced a $10 million private placement and a new manufacturing deal with Syrma Johari MedTech. The placement, priced at $4.35 per share and warrants, is set well below the closing price. Volume hit 108 million shares. The company recently enacted a 1-for-10 reverse split after a Nasdaq minimum bid warning.
1 January 2026
··
Nike stock jumps on CEO’s $1 million buy — what NKE investors watch next

Nike stock jumps on CEO’s $1 million buy — what NKE investors watch next

Nike shares rose 4.1% to $63.71 in the final 2025 session after CEO Elliott Hill bought 16,388 shares for about $1 million, according to an SEC filing. The gain came as Wall Street closed the year lower and Under Armour shares fell 3%. Trading volumes were thin ahead of the New Year’s Day market holiday. Investors are watching for updates on Nike’s margins and China demand as earnings approach.
1 January 2026
·
Ford stock today: F slips in thin year-end session as traders eye insider filing and Feb. 10 earnings

Ford stock today: F slips in thin year-end session as traders eye insider filing and Feb. 10 earnings

Ford Motor shares slipped 0.6% to $13.16 in thin year-end trading Wednesday, with about 16.5 million shares changing hands. A Form 4 filing showed Executive Chair William Clay Ford Jr. and director Alexandra Ford English made gifts and transfers of Class B stock at $0 per share on Dec. 22. General Motors, Stellantis, and Tesla also traded lower. Ford will report Q4 and full-year results on Feb. 10.
31 December 2025
··
Sunrun stock drops today as Treasury yields tick higher in year-end trading

Sunrun stock drops today as Treasury yields tick higher in year-end trading

Sunrun Inc. shares dropped 3.8% to $18.37 in afternoon trading Wednesday, tracking declines across solar stocks as U.S. Treasury yields edged higher. The stock traded between $18.34 and $19.20, with little company-specific news. Sunrun last announced a partnership with NRG Energy on Dec. 16. Investors are watching labor data and interest rates for further signals.
31 December 2025
··
BillionToOne (BLLN) stock slides 4% in thin year-end trade as investors look to January catalysts

BillionToOne (BLLN) stock slides 4% in thin year-end trade as investors look to January catalysts

BillionToOne shares fell 4% to $81.61 in thin trading on the last day of 2025, underperforming diagnostics peers. The company last reported third-quarter revenue of $83.5 million, up 117% year over year, and forecast full-year revenue of $293 million to $299 million. No new company disclosures appeared Wednesday. Management is set to present at the J.P. Morgan Healthcare Conference on Jan. 12.
31 December 2025
··
Why Super Micro (SMCI) stock is down today: an exec retirement filing meets year-end AI trade

Why Super Micro (SMCI) stock is down today: an exec retirement filing meets year-end AI trade

Super Micro Computer shares fell 1.7% to $29.15 after a filing showed Senior VP of Operations George Kao will retire Dec. 31, with Tom Xiao set to replace him. The company said Kao will help with the transition as a consultant. The move came as investors watched AI infrastructure spending, highlighted by xAI’s purchase of a third building to expand compute capacity. Major U.S. indexes drifted lower in thin holiday trading.
31 December 2025
····
Cytokinetics stock jumps today as CYTK traders focus on Myqorzo launch and insider filing

Cytokinetics stock jumps today as CYTK traders focus on Myqorzo launch and insider filing

Cytokinetics shares climbed 3.7% to $63.63 Wednesday, bucking a weaker market as investors awaited Myqorzo’s U.S. launch in January. A Form 4 showed Chief Commercial Officer Andrew Callos sold 1,809 shares at $62.44 on Dec. 29 under a pre-set plan. The drug, approved this month, will be distributed with a REMS safety program. Investors are watching for pricing details and initial uptake.
31 December 2025
··
1 … 329 330 331 332 333 … 584

Stock Market Today

  • C.H. Robinson Q1 2026 Sales Miss Estimates Despite Earnings Beat
    April 29, 2026, 5:25 PM EDT. Freight logistics firm C.H. Robinson Worldwide (NASDAQ:CHRW) reported Q1 CY2026 revenue of $4.01 billion, slightly below analyst forecasts of $4.04 billion, marking a flat year-on-year performance. However, adjusted earnings per share (EPS) came in at $1.35, beating estimates by 9.6%. Operating income and margin missed projections, reflecting ongoing supply constraints in the North American trucking market, according to CEO Dave Bozeman. The company's long-term sales have declined at a 1.2% annual rate over five years, with recent two-year revenue decreases driven by a 17.2% drop in its Global Forwarding segment. Analysts predict a 5.5% revenue rebound over the next year, suggesting potential growth from new services amid a challenging market backdrop. C.H. Robinson's market cap stands at $22.15 billion.

Latest article

Nebius Stock Jumps as Meta’s AI Spending Reset Puts $27 Billion Deal in Focus

Nebius Stock Jumps as Meta’s AI Spending Reset Puts $27 Billion Deal in Focus

29 April 2026
Nebius Group N.V. shares rose 5.3% to $142.73 Wednesday as Meta Platforms raised its 2026 capital spending forecast by up to $10 billion, citing higher data center costs. Nebius has a contract to supply Meta with up to $27 billion in AI cloud capacity. Fourth-quarter 2025 revenue jumped 547% to $227.7 million, but the company reported a net loss of $249.6 million.
Phillips 66 Stock Jumps as Surprise Profit Shows Refining Margins Are Back in Focus

Phillips 66 Stock Jumps as Surprise Profit Shows Refining Margins Are Back in Focus

29 April 2026
Phillips 66 reported an adjusted first-quarter profit of $200 million, or 49 cents per share, beating analyst forecasts of a loss. Strong refining margins and 95% plant utilization offset $839 million in hedge-related losses. Shares rose over 6% after the results. The company also completed its acquisition of Lindsey Oil Refinery assets in the UK.
Extreme Networks Stock Jumps as Q3 Earnings Beat Puts Cisco, HPE Rivals in Focus

Extreme Networks Stock Jumps as Q3 Earnings Beat Puts Cisco, HPE Rivals in Focus

29 April 2026
Extreme Networks shares surged 28% after reporting fiscal Q3 revenue of $316.9 million, up 11%, and non-GAAP earnings of 26 cents per share, both above estimates. The company forecast Q4 revenue of $330–$335 million, topping FactSet’s $326.9 million estimate. SaaS annual recurring revenue rose 28.6% to $236.4 million. Net income climbed to $10.6 million from $3.5 million a year earlier.
Go toTop